| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates
|
Farrell, David J.
|
|
2010
|
35 |
6 |
p. 537-543
7 p.
|
article
|
| 2 |
Augmented renal clearance in the Intensive Care Unit: an illustrative case series
|
Udy, Andrew A.
|
|
2010
|
35 |
6 |
p. 606-608
3 p.
|
article
|
| 3 |
Characterisation of qnr plasmid-mediated quinolone resistance in Enterobacteriaceae from Italy: association of the qnrB19 allele with the integron element ISCR1 in Escherichia coli
|
Richter, Sara N.
|
|
2010
|
35 |
6 |
p. 578-583
6 p.
|
article
|
| 4 |
2-Chloroadenosine (2-CADO) treatment modulates the pro-inflammatory immune response to prevent acute lung inflammation in BALB/c mice suffering from Klebsiella pneumoniae B5055-induced pneumonia
|
Kumar, Vijay
|
|
2010
|
35 |
6 |
p. 599-602
4 p.
|
article
|
| 5 |
Comparative efficacy of novobiocin and amoxicillin in experimental sepsis caused by β-lactam-susceptible and highly resistant pneumococci
|
Rodríguez-Cerrato, Violeta
|
|
2010
|
35 |
6 |
p. 544-549
6 p.
|
article
|
| 6 |
Comparison of two DNA microarrays for detection of plasmid-mediated antimicrobial resistance and virulence factor genes in clinical isolates of Enterobacteriaceae and non-Enterobacteriaceae
|
Walsh, Fiona
|
|
2010
|
35 |
6 |
p. 593-598
6 p.
|
article
|
| 7 |
Detection of the first two Klebsiella pneumoniae isolates with sequence type 258 producing KPC-2 carbapenemase in Denmark
|
Hammerum, Anette M.
|
|
2010
|
35 |
6 |
p. 610-612
3 p.
|
article
|
| 8 |
Editorial Board
|
|
|
2010
|
35 |
6 |
p. i-
1 p.
|
article
|
| 9 |
Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria
|
Nicolosi, Daria
|
|
2010
|
35 |
6 |
p. 553-558
6 p.
|
article
|
| 10 |
Fatal bacteraemia and infective endocarditis due to meticillin-resistant Staphylococcus aureus (MRSA) with rapid emergence of rifampicin resistance during vancomycin/rifampicin combination treatment
|
Liu, Wei-Lun
|
|
2010
|
35 |
6 |
p. 615-616
2 p.
|
article
|
| 11 |
First description of Klebsiella pneumoniae clinical isolates carrying both qnrA and qnrB genes in Portugal
|
Ferreira, Sónia
|
|
2010
|
35 |
6 |
p. 584-586
3 p.
|
article
|
| 12 |
Interaction of the antimicrobial peptide melimine with bacterial membranes
|
Rasul, R.
|
|
2010
|
35 |
6 |
p. 566-572
7 p.
|
article
|
| 13 |
In vitro activities of fosfomycin and carbapenem combinations against carbapenem non-susceptible Escherichia coli and Klebsiella pneumoniae
|
Netikul, Thidarat
|
|
2010
|
35 |
6 |
p. 609-610
2 p.
|
article
|
| 14 |
In vitro activity of tigecycline in Plasmodium falciparum culture-adapted strains and clinical isolates from Gabon
|
Held, Jana
|
|
2010
|
35 |
6 |
p. 587-589
3 p.
|
article
|
| 15 |
In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species
|
Farrell, David J.
|
|
2010
|
35 |
6 |
p. 531-536
6 p.
|
article
|
| 16 |
In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii
|
Li, Houmin
|
|
2010
|
35 |
6 |
p. 550-552
3 p.
|
article
|
| 17 |
In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates
|
Vidaillac, Céline
|
|
2010
|
35 |
6 |
p. 527-530
4 p.
|
article
|
| 18 |
In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections
|
Desbois, Andrew P.
|
|
2010
|
35 |
6 |
p. 559-565
7 p.
|
article
|
| 19 |
Macrolide-resistant Streptococcus pyogenes in Central Greece: prevalence; mechanism and molecular identification
|
Malli, Ergina
|
|
2010
|
35 |
6 |
p. 614-615
2 p.
|
article
|
| 20 |
Microbiological outcome of complicated urinary tract infections treated with levofloxacin: a pharmacokinetic/pharmacodynamic analysis
|
Deguchi, Takashi
|
|
2010
|
35 |
6 |
p. 573-577
5 p.
|
article
|
| 21 |
Panton–Valentine leukocidin-producing Staphylococcus aureus necrotising pneumonia: measuring toxin levels in microbiological samples to attest of linezolid clinical efficacy
|
Pasquier, P.
|
|
2010
|
35 |
6 |
p. 613-614
2 p.
|
article
|
| 22 |
Pharmacokinetics of garenoxacin in elderly patients with respiratory tract infections
|
Ohsaki, Yoshinobu
|
|
2010
|
35 |
6 |
p. 603-605
3 p.
|
article
|
| 23 |
Prevalence and molecular mechanism of macrolide resistance in β-haemolytic streptococci in The Netherlands
|
Van Leer Buter, C.C.
|
|
2010
|
35 |
6 |
p. 590-592
3 p.
|
article
|
| 24 |
Rapid induction of resistance to the fluoroquinolone enrofloxacin in Pseudomonas putida NCTC 10936
|
Schuurmans, J. Merijn
|
|
2010
|
35 |
6 |
p. 612-613
2 p.
|
article
|
| 25 |
Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns
|
Tupin, Audrey
|
|
2010
|
35 |
6 |
p. 519-523
5 p.
|
article
|
| 26 |
Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!
|
Amaral, Leonard
|
|
2010
|
35 |
6 |
p. 524-526
3 p.
|
article
|
Journal description